Guidelines for the use of tumor markers in breast cancer
The best-validated markers in breast cancer are all tissue based and include estrogen receptors (ER), progesteron receptors (PR), HER-2, urokinase plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1). Assay of ER, PR and HER-2 is now mandatory on all newly diagnosed breast cance...
Main Author: | Ignjatović Svetlana |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Medical Biochemists of Serbia, Belgrade
2007-01-01
|
Series: | Journal of Medical Biochemistry |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2007/0354-34470702144I.pdf |
Similar Items
-
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients
by: Engelstaedter Verena, et al.
Published: (2012-12-01) -
Response to chemotherapy and association with three tumour markers in breast cancer patients in Ghana
by: Emmanuel Amankwaa Frempong, et al.
Published: (2014-08-01) -
Tumor marker CA 15-3 in breast cancer patients
by: Hanifa Fejzić, et al.
Published: (2015-05-01) -
Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67
by: Xu J, et al.
Published: (2018-04-01) -
Determination of Cancer Antigen CA15-3 and Carcino Embryonic Antigen CEA concentration as Tumor Markers in Patients with Stomach and Colorectal cancers.
by: Rana. K. AL-saady, et al.
Published: (2012-10-01)